ACE2 and COVID-19: This is due to the decrease in total respiratory system compliance associated with obesity conditions, but also because in adipose tissue, the expression of ACE2 is higher than in lung tissue, the main target tissue affected by COVID-19 and other viruses like influenza [14,16,17].